Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulators
Authors
Keywords
Orexin, Hypocretin, Benzodiazepine, Insomnia, Sleep, Electroencephalography, Sleep deprivation, REM sleep, NREM sleep, Suvorexant, Belsomra
Journal
BMC NEUROSCIENCE
Volume 15, Issue 1, Pages 109
Publisher
Springer Nature
Online
2014-09-22
DOI
10.1186/1471-2202-15-109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
- (2014) David Michelson et al. LANCET NEUROLOGY
- The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam
- (2014) Brittany T. Wright et al. PSYCHOPHARMACOLOGY
- The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
- (2013) Anthony L Gotter et al. BMC NEUROSCIENCE
- Discovery and development of orexin receptor antagonists as therapeutics for insomnia
- (2013) C J Winrow et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sleep deprivation and neurobehavioral dynamics
- (2013) Mathias Basner et al. CURRENT OPINION IN NEUROBIOLOGY
- Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats
- (2013) Steven V Fox et al. NEUROPSYCHOPHARMACOLOGY
- Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant
- (2012) W. J. Herring et al. NEUROLOGY
- Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep and EEG Power Spectra in a Model of Situational Insomnia
- (2012) Paolo Bettica et al. NEUROPSYCHOPHARMACOLOGY
- Insomnia Pharmacotherapy
- (2012) Timothy Roehrs et al. Neurotherapeutics
- Sleep Deprivation Impairs Consolidation of Cued Fear Memory in Rats
- (2012) Tankesh Kumar et al. PLoS One
- Benzodiazepines revisited-will we ever learn?
- (2011) Malcolm Lader ADDICTION
- Orexin Receptors: Pharmacology and Therapeutic Opportunities
- (2011) Thomas E. Scammell et al. Annual Review of Pharmacology and Toxicology
- Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
- (2011) Christopher J. Winrow et al. JOURNAL OF NEUROGENETICS
- Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
- (2011) Christopher J. Winrow et al. NEUROPHARMACOLOGY
- British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
- (2010) SJ Wilson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Zolpidem-induced changes in activity, metabolism, and anxiety in rats
- (2010) Helen M. Murphy et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics
- (2009) David J Nutt et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Sleep deprivation impairs cAMP signalling in the hippocampus
- (2009) Christopher G. Vecsey et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started